日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MMP1-induced NF-κB activation promotes epithelial-mesenchymal transition and sacituzumab govitecan resistance in hormone receptor-positive breast cancer.

MMP1 诱导的 NF-κB 激活促进激素受体阳性乳腺癌的上皮-间质转化和 sacituzumab govitecan 耐药性

Chen Letian, Cen Yinghuan, Qian Keyang, Yang Wang, Zhou Wenbin, Yang Yaping

Correction: Lin et al. Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in Bone. Cancers 2021, 13, 5703

更正:Lin 等人,《沉默 CTNND1 通过上调 CXCR4/CXCL12 轴和中性粒细胞浸润骨组织介导三阴性乳腺癌骨转移》,Cancers 2021, 13, 5703

Lin, Qun; Fang, Xiaolin; Liang, Gehao; Luo, Qing; Cen, Yinghuan; Shi, Yu; Jia, Shijie; Li, Juanmei; Yang, Wenqian; Sanders, Andrew J; Gong, Chang; Jiang, Wenguo

Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics

RNA结合蛋白在乳腺癌耐药性中的新作用:从分子生物学到靶向治疗

Cen, Yinghuan; Chen, Letian; Liu, Zihao; Lin, Qun; Fang, Xiaolin; Yao, Herui; Gong, Chang

Attenuation of PITPNM1 Signaling Cascade Can Inhibit Breast Cancer Progression

抑制PITPNM1信号级联可抑制乳腺癌进展

Liu, Zihao; Shi, Yu; Lin, Qun; Yang, Wenqian; Luo, Qing; Cen, Yinghuan; Li, Juanmei; Fang, Xiaolin; Jiang, Wen G; Gong, Chang

MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYL

miR-92b-3p通过靶向circCDYL抑制HER2阳性乳腺癌细胞的增殖

Liang, Gehao; Ling, Yun; Lin, Qun; Shi, Yu; Luo, Qing; Cen, Yinghuan; Mehrpour, Maryam; Hamai, Ahmed; Li, Jun; Gong, Chang

Denervation in Femoral Artery-Ligated Hindlimbs Diminishes Ischemic Recovery Primarily via Impaired Arteriogenesis.

股动脉结扎后肢的去神经支配主要通过损害动脉生成来降低缺血恢复能力

Cen Yinghuan, Liu Junfeng, Qin Yuansen, Liu Ruiming, Wang Huijin, Zhou Yu, Wang Shenming, Hu Zuojun